Prism Tabs Full Spectrum Kratom Tablets 1300mg
Five scored full-spectrum kratom extract tablets labeled with 180 mg mitragynine and 260 mg kratom extract per tablet. Adults 21+; review the directions, warnings, ingredients, and batch 180MIT report.
Package label facts
- Package
- 5 scored tablets (0.65 g each; 3.25 g total)
- Serving size
- 1/4 tablet (0.16 g)
- Servings per package
- 20
- Per serving
- 65 mg kratom (Mitragyna speciosa) extract; 45 mg mitragynine
- Per tablet
- 260 mg extract; 180 mg mitragynine
- Per package
- 1,300 mg extract; 900 mg mitragynine
| Alkaloid | Per 1/4-tablet serving | Per tablet |
|---|---|---|
| Mitragynine | 45 mg | 180 mg |
| Paynantheine | 6.25 mg | 25 mg |
| Speciogynine | 4.75 mg | 19 mg |
| Corynantheidine | 1.25 mg | 5 mg |
| Speciociliatine | 8.5 mg | 34 mg |
Suggested serving
The label directs adults 21+ to take 1/4 tablet every 4 hours and not exceed 260 mg in a 24-hour period. Consult a doctor before use or if side effects occur.
Other ingredients
Sorbitol, magnesium stearate, natural/artificial flavoring, silicon dioxide, bitter blocker, and natural/artificial coloring.
Warnings
- Adults 21+ only.
- Do not operate heavy machinery.
- Do not consume if pregnant or taking prescription medication.
- Keep out of reach of children and pets.
Manufactured by Bedrock Botanicals, 3678 E Lanark St., Meridian, ID 83642. UPC 272113220235.
The package's Florida Mandatory Alkaloid Disclosure lists mitragynine at 180 mg per tablet and the designated 7-hydroxymitragynine compounds and isomers at 0.00 mg/g (not detected).
The label states that this product is not intended to diagnose, treat, cure, or prevent any medical condition or disease and that its statements have not been evaluated by the FDA.
Product and batch report
View the available report and match its product, batch or lot, analytes, and report date to the item in hand. Package reference: Batch 180MIT; laboratory sample ICC-260206-12-001.
Current price, availability, variants, and purchase controls appear only after the storefront responds.